Wedbush analyst Robert Driscoll initiated coverage of Avalo Therapeutics (AVTX) with an Outperform rating and $18 price target Discover the ...
Welltower (NYSE:WELL) was upgraded at Wedbush after the senior housing REIT "impressed with the growth outlook for 2025". The healthcare REIT turned in Q4 earnings and revenue that topped Wall ...
Trading Technologies and Wedbush. Palmer told the press that “our upcoming launch of margin futures represents a significant milestone for CBOE Digital, and we are grateful to have the support of ...
U.S. stocks surged on Wednesday, with all three major indexes registering their biggest daily percentage gains in more than two months, as lower-than-expected December core inflation data and solid ...
But now there is one analyst who’s again projecting upside: Wedbush’s Daniel Ives boosted his target price to $90 on Thursday morning. Palantir’s stock PLTR closed at $76.87 on Wednesday ...
Wedbush is one of only six U.S. firms offering equity and futures clearing, as well as being a registered swap dealer. With a legacy of trust and innovation, Wedbush is committed to empowering ...
Wedbush lowered the firm’s price target on LGI Homes (LGIH) to $115 from $125 and keeps a Neutral rating on the shares. The firm notes Q4’s reported closings of 1,636 were below its 1,800 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback